7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Bone Neoplasms D001859 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hot Flashes D019584 5 associated lipids
Mandibular Diseases D008336 5 associated lipids
Biliary Atresia D001656 4 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Hypercalciuria D053565 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Periapical Diseases D010483 4 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Diabetes Complications D048909 4 associated lipids
Tinnitus D014012 4 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Fractures, Bone D050723 4 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Jaw Diseases D007571 4 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Addison Disease D000224 3 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hirsutism D006628 3 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Periapical Granuloma D010484 3 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Mastocytoma D034801 3 associated lipids
Progeria D011371 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Measles D008457 3 associated lipids
Hearing Loss D034381 3 associated lipids
Malocclusion D008310 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Angina, Stable D060050 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Akatsu T et al. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. 1998 Biochem. Biophys. Res. Commun. pmid:9753612
Takai H et al. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. 1998 J. Biol. Chem. pmid:9765225
Filvaroff E and Derynck R Bone remodelling: a signalling system for osteoclast regulation. 1998 Curr. Biol. pmid:9768352
Hofbauer LC et al. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. 1998 Biochem. Biophys. Res. Commun. pmid:9784422
Hakeda Y et al. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. 1998 Biochem. Biophys. Res. Commun. pmid:9790989
Horwood NJ et al. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. 1998 Endocrinology pmid:9794488
Vidal NO et al. Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. 1998 J. Endocrinol. pmid:9795357
Yun TJ et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. 1998 J. Immunol. pmid:9834095
Murakami T et al. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. 1998 Biochem. Biophys. Res. Commun. pmid:9837778
Akatsu T et al. Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. 1998 Bone pmid:9855457
Schinke T et al. Molecular determinants of arterial calcification. 1998 Ann. Med. pmid:9920355

Table of Content